ZINZINO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 72.8 SEK | -1.36% |
|
+3.85% | +22.15% |
| Sales 2023 | 1.77B 162M 221M | Sales 2024 * | 1.92B 175M 240M | Capitalization | 2.52B 230M 315M |
|---|---|---|---|---|---|
| Net income 2023 | 164M 15.01M 20.51M | Net income 2024 * | 179M 16.38M 22.39M | EV / Sales 2023 | 1.29 x |
| Net Debt 2023 | 257M 23.53M 32.16M | Net Debt 2024 * | 221M 20.23M 27.64M | EV / Sales 2024 * | 1.43 x |
| P/E ratio 2023 |
12.6
x | P/E ratio 2024 * |
14.6
x | Employees | 221 |
| Yield 2023 |
5.03% | Yield 2024 * |
2.71% | Free-Float | 53.08% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.36% | ||
| 1 week | +3.85% | ||
| Current month | -4.46% | ||
| 1 month | -5.94% | ||
| 3 months | +2.25% | ||
| 6 months | +87.15% | ||
| Current year | +22.15% |
1 week
68.60
74.50
1 month
68.3080.80
Current year
58.4085.80
1 year
35.5085.80
3 years
24.0085.80
5 years
11.7591.80
10 years
6.8691.80
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 11-12-31 | |
Fredrik Nielsen
DFI | Director of Finance/CFO | 47 | 08-12-31 |
| Chief Tech/Sci/R&D Officer | 48 | 17-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 06-12-31 | |
Anna Maria Frick
BRD | Director/Board Member | 56 | - |
| Director/Board Member | 52 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-29 | 72.8 | -1.36% | 17 435 |
| 24-04-26 | 73.8 | +3.65% | 19,538 |
| 24-04-25 | 71.2 | +1.28% | 37,360 |
| 24-04-24 | 70.3 | -0.85% | 46,132 |
| 24-04-23 | 70.9 | +1.14% | 15,873 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 09:37 am
More quotes
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Companyâs test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Companyâs headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Sector
Other Specialty Retailers
Calendar
2024-05-21
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.15% | 229M | |
| -.--% | 843M | |
| -0.79% | 657M | |
| +5.50% | 384M | |
| 0.00% | 141M | |
| +115.22% | 65.28M |
- Stock Market
- Equities
- ZZ B Stock
